SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Pfizer
Pfizer
BSE: 500680|NSE: PFIZER|ISIN: INE182A01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 17:00
1587.60
26.6 (1.7%)
VOLUME 1,576
LIVE
NSE
Oct 23, 17:00
1590.65
25.15 (1.61%)
VOLUME 5,170
News on Pfizer
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Pfizer; target of Rs 1797: Firstcall Research

12.29 pm | 07 Oct 2014 |  Source: Moneycontrol.com

Firstcall Research is bullish on Pfizer and has recommended buy rating on the stock with a target of Rs 1797 in its September 29, 2014 research report...

Pfizer, Ranbaxy win dismissal of lawsuit over Lipitor

12.41 pm | 13 Sep 2014 |  Source: Reuters

The lawsuit stems from a 2008 settlement of a patent lawsuit filed by Pfizer against Ranbaxy over Ranbaxy's plan to make generic Lipitor. Under the de...

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

3.31 pm | 31 Jul 2014 |  Source: Reuters

On the back of the strong results, AstraZeneca raised its guidance for the full year, predicting sales would hold steady and not decline as previously...

Pfizer Q1 net dips 3% at Rs 46 cr

4.51 pm | 24 Jul 2014 |  Source: PTI

Net sales of Pfizer, rose to Rs 239.85 crore during the first quarter, as compared to Rs 237.53 crore in the same period of previous fiscal...

Pfizer India Q4 revenue stands flat QoQ at Rs 251.69cr

3.49 pm | 03 May 2014 |  Source: Moneycontrol.com

Pfizer announced its fourth quarter earnings on May 2, with revenue for the period standing at Rs 251.69 crore, compared to Rs 252.19 crore year-on-ye...

1 2
Quick Links for Pfizer
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.